Sanders targets drug companies over COVID-19 vaccine price hikes, high prescription costs
CBSN
Vermont Sen. Bernie Sanders took aim at pharmaceutical companies on Sunday over upcoming price hikes for COVID-19 vaccines and high prescription drug prices more broadly, telling "Face the Nation" that he believes there is room for bipartisanship to bring down costs for working class Americans.
The independent senator recently called on Moderna's chief executive officer Stéphane Bancel to testify before the Senate Health, Education, Labor and Pensions (HELP) Committee, which he chairs. Sanders called the hearing after the company suggested it would quadruple the price of COVID-19 vaccines once the shots transition to the private market.
On Sunday, Sanders noted that U.S. gave Moderna billions of dollars to develop its vaccine. U.S. officials have said stockpiles of government-bought vaccines could run out by this summer.
